Publication details

Přínos ERG v časné diagnostice chlorochinové a hydroxychlorochinové makulopatie

Title in English The ERG Contribution in Early Diagnosis of Chloroquine and Hydroxychloroquine Maculopathy
Authors

KARKANOVÁ Michala MATUŠKOVÁ Veronika VLKOVÁ Eva DOŠKOVÁ Hana

Year of publication 2010
Type Article in Periodical
Magazine / Source Česká a Slovenská Oftalmologie
MU Faculty or unit

Faculty of Medicine

Citation
Field ORL, ophthalmology, stomatology
Keywords ERG, antimalarica, drug cumulative maculopathy
Description Derivates of chloroquine (Plaquenil, Delagil) used for long-term treatment of rheumatic diseases may cause clinically proven irreversible maculopathy, which may progress even after the discontinuation of their application. The optimal early diagnosis of ocular toxicity of chloroquine or hydroxychloroquine drug remains controversial up to now. The aim of this review paper was to evaluate how appropriate is the indication of the electroretinographic (ERG) examination due to early diagnosis of cumulative drug-related maculopathy. Photopic, pattern and multifocal ERG were examinated in 10 patients (20 eyes) treated by means of antimalarics, 9 due to the rheumatoid arthritis (RA) and 1 due to the systemic lupus erythemathodes (SLE). The control group consisted of 12 healthy (20 eyes)age matched patients.The significant difference between the group treated with chloroquine or hydroxychloroquine and the control group at the 1% level of significance was found in the photopic ERG the value of the b wave latency, in pattern ERG, the values of the waves N35-P50 and P50-N95 amplitudes, and at the 5% level of significance in photopic ERG, the wave a amplitude value and in multifocal ERG, the value of the P1 a N1 parts latency in the pericentral ring. It follows from the results, that the ERG examination is suitable for the early diagnosis drug cumulative maculopathy caused by chloroquine derivates.

You are running an old browser version. We recommend updating your browser to its latest version.

More info